141 related articles for article (PubMed ID: 17270032)
1. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes.
Suzuki M; Shinkai M; Honda H; Kobayashi T
Melanoma Res; 2003 Apr; 13(2):129-35. PubMed ID: 12690295
[TBL] [Abstract][Full Text] [Related]
3. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
Sato M; Yamashita T; Ohkura M; Osai Y; Sato A; Takada T; Matsusaka H; Ono I; Tamura Y; Sato N; Sasaki Y; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
J Invest Dermatol; 2009 Sep; 129(9):2233-41. PubMed ID: 19295615
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
[TBL] [Abstract][Full Text] [Related]
5. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
Shinkai M; Yanase M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1996 Nov; 87(11):1179-83. PubMed ID: 9045948
[TBL] [Abstract][Full Text] [Related]
6. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Tanaka K; Kondo K; Shinkai M; Honda H; Matsumoto K; Saida T; Kobayashi T
Cancer Sci; 2003 Mar; 94(3):308-13. PubMed ID: 12824927
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
Int J Cancer; 2005 Sep; 116(4):624-33. PubMed ID: 15825167
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
Sato A; Tamura Y; Sato N; Yamashita T; Takada T; Sato M; Osai Y; Okura M; Ono I; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
Cancer Sci; 2010 Sep; 101(9):1939-46. PubMed ID: 20594194
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Ito S
Melanoma Res; 2004 Apr; 14(2):115-20. PubMed ID: 15057040
[TBL] [Abstract][Full Text] [Related]
11. A Sulfur Containing Melanogenesis Substrate,
Tamura Y; Ito A; Wakamatsu K; Torigoe T; Honda H; Ito S; Jimbow K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982309
[No Abstract] [Full Text] [Related]
12. Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone.
Kawai N; Futakuchi M; Yoshida T; Ito A; Sato S; Naiki T; Honda H; Shirai T; Kohri K
Prostate; 2008 May; 68(7):784-92. PubMed ID: 18302228
[TBL] [Abstract][Full Text] [Related]
13. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
14. In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.
Kitagawa M; Nemoto T; Seki S; Ito S; Kasuga T
J Cancer Res Clin Oncol; 1993; 119(8):470-4. PubMed ID: 8099588
[TBL] [Abstract][Full Text] [Related]
15. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
Ito Y; Jimbow K
Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
Inoue S; Hasegawa K; Wakamatsu K; Ito S
Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
[TBL] [Abstract][Full Text] [Related]
17. Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase.
Parsons PG; Favier D; McEwan M; Takahashi H; Jimbow K; Ito S
Melanoma Res; 1991; 1(2):97-104. PubMed ID: 1823629
[TBL] [Abstract][Full Text] [Related]
18. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
[TBL] [Abstract][Full Text] [Related]
19. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
[TBL] [Abstract][Full Text] [Related]
20. Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core.
Kawai N; Ito A; Nakahara Y; Honda H; Kobayashi T; Futakuchi M; Shirai T; Tozawa K; Kohri K
Prostate; 2006 May; 66(7):718-27. PubMed ID: 16425185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
